Loading...
01/10 16:58
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents a mixed picture. While there is strong growth in gross billings and EPS, there are concerns about regulatory issues, staffing business decline, and investment income. The Q&A session indicates stability and recovery but lacks clarity on workers' comp pricing. The strategic partnership with Kaiser Permanente is a positive, but the lack of market cap data limits impact assessment. The shareholder return plan is positive, but economic factors and client payroll tax rates pose risks. Overall, the sentiment is neutral with a slight positive tilt.
Gross Billings (Q4 2024) $2.25 billion (up 10% year-over-year from $2.05 billion in Q4 2023) due to strong client retention and new client additions.
Gross Billings (Full Year 2024) $8.3 billion (up 7.9% year-over-year from $7.7 billion in 2023) driven by a 4.2% growth in average worksite employees.
Diluted Earnings Per Share (Q4 2024) $0.63 (up 17% year-over-year from $0.54 in Q4 2023) attributed to increased gross billings and improved client hiring.
Diluted Earnings Per Share (Full Year 2024) $1.98 (up 7% year-over-year from $1.85 in 2023) reflecting overall growth in gross billings.
Staffing Revenues (Q4 2024) $20 million (down 9% year-over-year) due to a decline in staffing operations, although the rate of decline has slowed.
PEO Worksite Employees Growth (Q4 2024) 5.2% growth year-over-year, driven by a record number of new client additions.
Average Billing per Worksite Employee (Q4 2024) Increased by 3.3% year-over-year, reflecting wage rate increases.
SG&A Expense (Q4 2024) Increased 7% year-over-year, primarily due to higher variable employee compensation and incentive pay.
Investment Income (Q4 2024) $2.5 million (down approximately $300,000 year-over-year) due to lower average interest rates.
Cash and Investments (December 31, 2024) $122 million of unrestricted cash investments with no debt.
Capital Return to Shareholders (Full Year 2024) $37 million, including over $8 million in dividends and $29 million in share repurchases.
BBSI Benefits: Successfully selling and servicing BBSI Benefits in all markets, with a record number of clients and participants.
Applicant Tracking System: Launch of a new Applicant Tracking System to streamline hiring processes for clients.
Market Expansion: Expanded into new geographies with 21 new market development managers and positive results from new market entries.
Client Retention Rate: Achieved a record client retention rate, with a Net Promoter Score increase of 5 points to 69.
Staffing Operations: Staffing business declined by 9%, but the rate of decline has slowed significantly.
Strategic Partnerships: Entered into a multiyear partnership with a new carrier for BBSI Benefits.
Investment in Technology: Continued investment in tech stack and myBBSI to enhance service offerings and operational efficiencies.
Competitive Pressures: The company faces competitive pressures in the staffing industry, particularly as it seeks to penetrate white-collar verticals where it has previously struggled.
Regulatory Issues: Client payroll tax rates have increased in 2025, which may impact earnings due to the lag in pricing adjustments.
Supply Chain Challenges: The company has not explicitly mentioned supply chain challenges, but the overall economic environment may pose indirect risks.
Economic Factors: Client hiring trends remain below historical averages, which could affect future growth despite recent improvements.
Investment Income: Investment income is expected to decline due to lower average interest rates, impacting overall financial performance.
Staffing Business Decline: The staffing business has seen a decline of 9% year-over-year, although the rate of decline has slowed.
Workers' Compensation Pricing: There is expected continued softness in workers' compensation pricing, which could affect profitability.
Strategic Partnerships: Entered into a strategic multiyear partnership with a new carrier for the 1/1/2025 selling season.
Sales Initiatives: Operationalized strategic sales initiatives resulting in record worksite employees (WSEs) from new clients.
Client Retention: Achieved a record client retention rate for the year, attributed to the value provided to clients.
Product Development: Invested in myBBSI and tech stack, resulting in multiple product releases in 2024 and new launches planned for 2025.
Employer Choice Initiative: Further advancements made, earning the Great Place to Work designation for the fourth consecutive year.
New Market Development: Expanded into new geographies with 21 new market development managers, adding over 500 new WSEs in January.
BBSI Benefits: Successfully increased clients from 275 to approximately 575, with over 16,000 participants in health insurance plans.
IT Product Objectives: Investments in tech stack to enhance employee life cycle experience and launch new products in 2025.
2025 Gross Billings Growth: Expected to increase between 7% and 9%.
2025 Average WSE Growth: Expected to increase between 4% and 6%.
2025 Gross Margin: Expected to remain consistent with 2024, ranging between 2.85% and 3.10%.
Effective Annual Tax Rate: Expected to be between 26% and 27%.
Investment Income: Expected to decrease due to lower average interest rates.
Capital Allocation: Continue to invest excess cash flow into the company and return capital to shareholders through dividends and stock buybacks.
Dividends Paid in 2024: BBSI paid over $8 million in dividends for the year.
Share Repurchase Program: Under the $75 million repurchase program initiated in July 2023, BBSI repurchased $7 million of shares in Q4 at an average price of $43 per share, with $30 million remaining available under the program at quarter end.
Total Shares Repurchased in 2024: In total, BBSI repurchased over 3% of the company's shares outstanding through purchases of more than $29 million.
Total Capital Return to Shareholders in 2024: Total capital return to shareholders in 2024 amounted to $37 million.
The earnings call summary shows strong financial performance with positive growth in gross billings and worksite employees, and optimistic market opportunities due to inflationary pressures. The Q&A section highlights successful branch openings, a healthy client pipeline, and technological advancements, although some uncertainty remains about the exact impact of the increased healthcare quote pipeline. Overall, the sentiment is positive, driven by growth opportunities, successful expansions, and product development plans.
The earnings call suggests a positive outlook with strong financial performance, growth in new client sales, and market expansion. Despite some regional challenges, the company raised its guidance for the year, indicating confidence in its strategies. The Q&A session highlighted favorable workers' compensation adjustments and technology enhancements aiding market positioning. Although there were some unclear responses, the overall sentiment remains positive, supported by increased net income and strategic expansion plans.
The earnings call summary shows strong financial performance with a 9.5% increase in gross billings and a 7.6% growth in worksite employees. The strategic partnership and client retention are also positive indicators. Although there is a slight decline in staffing revenues and investment income, the company's strong balance sheet and shareholder returns through dividends and buybacks are favorable. The Q&A section revealed no major concerns, and the optimistic guidance of 7% to 9% growth supports a positive outlook. Overall, these factors suggest a positive stock price reaction over the next two weeks.
The earnings call summary presents a mixed picture. While there is strong growth in gross billings and EPS, there are concerns about regulatory issues, staffing business decline, and investment income. The Q&A session indicates stability and recovery but lacks clarity on workers' comp pricing. The strategic partnership with Kaiser Permanente is a positive, but the lack of market cap data limits impact assessment. The shareholder return plan is positive, but economic factors and client payroll tax rates pose risks. Overall, the sentiment is neutral with a slight positive tilt.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
